Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -15.846% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. Cc1cc(=O)[nH]c(/N=C(\N)Nc2ccc(SC(F)F)cc2)n1
b. O=C(Nc1ccc2oc(=O)ccc2c1)c1ccc(-c2cccc([N+](=O)[O-])c2)o1
c. CC(C)n1c(SCC(=O)NCc2ccco2)nnc1C1CC1
Answer: a. Cc1cc(=O)[nH]c(/N=C(\N)Nc2ccc(SC(F)F)cc2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(=O)[nH]c(/N=C(\N)Nc2ccc(SC(F)F)cc2)n1
Cc1cc(=O)[nH]c(/N=C(\N)Nc2ccc(SC(F)F)cc2)n1
1-[4-(difluoromethylsulfanyl)phenyl]-2-(4-methyl-6-oxo-1H-pyrimidin-2-yl)guanidine